The expression of LINC00665 in these two pair cell lines was validated by qRT-PCR, and our results demonstrated the apparently upregulation of LINC00665 in gemcitabine resistant CCA cells (Fig. 1C). The gene discussed is LINC00665; the disease is cholangiocarcinoma.